HK Stock Market Move | MEDBOT-B(02252) rose more than 12% in early trading. Tusmi Siasun Robot & Automation completes the installation of the 200th commercial unit worldwide.

date
11:13 03/07/2026
avatar
GMT Eight
Minimally Invasive Robot-B (02252) surged over 12% in early trading, as of the time of publication, it rose 12.53% to 26.22 Hong Kong dollars, with a turnover of 155 million Hong Kong dollars.
MEDBOT-B (02252) surged more than 12% in early trading, as of the time of writing, it has risen by 12.53% to 26.22 Hong Kong dollars, with a trading volume of 155 million Hong Kong dollars. On the news front, recently, Microport Siasun Robot & Automation announced that following the global commercialization orders of over 300 units for the group's core product, the Tuming Laparoscopic Surgery System, Tuming has recently landed at the top medical institution HM Hospitales in Spain, completing its 200th global commercial installation. All 200 installations have received acceptance reports from end customers. Microport Siasun Robot & Automation stated that in overseas markets, Tuming continues to rapidly expand its global presence in multiple regions, with commercial installations in over 60 countries and regions to date. Thanks to its scalable commercial installations and technological leadership in remote surgery, Tuming's brand influence ranks among the top two in the world. Guolian Minsheng Securities believes that since the second half of 2025, the company has transitioned from the "product introduction period" to the "high-growth period for orders."